Elif Atağ

Elif Atağ

Dokuz Eylül University - İzmir / Türkiye
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5946315
Dokuz Eylül Üniversitesi
person_outline Elif Atağ's MOST POPULAR ARTICLES
1-) Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for patients with neuroendocrine tumors: an Izmir Oncology Group Study Chemotherapy 61 (6), 281-286, 2016
2-) Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: results of real-life experiences European urology focus 7 (5), 1061-1066, 2021
3-) Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab International journal of clinical oncology 26, 1506-1513, 2021
4-) Prevalence of depressive symptoms in elderly cancer patients receiving chemotherapy and influencing factors Psychogeriatrics 18 (5), 365-370, 2018
5-) The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and … The Breast 70, 56-62, 2023